"The challenge for Cardiologs is to create this artificial intelligence that will reach the level of the best experts, who have already reached it for the diagnosis of heart rhythm disorders, and to make it available to everyone, worldwide, to accelerate the diagnosis and the management of all these patients", Yann Fleureau, CEO and founder of Cardiologs.The solution developed by Cardiologs is the first AI-based heart rhythm disorder diagnostic solution in the US, it was launched in Europe late last year. Yann Fleureau's projections are for 1 million patients to be diagnosed by the end of 2021. Translated from Cardiologs reçoit le prix du dispositif médical 2020 des grands prix BFM Business de la santé
Our articles will then appear first in Google Top Stories.
